Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

被引：0
|
作者：
Junshik Hong
Sae-Won Han
Hye Seon Ham
Tae-Yong Kim
In Sil Choi
Byung-Su Kim
Do-Youn Oh
Seock-Ah Im
Gyeong Hoon Kang
Yung-Jue Bang
Tae-You Kim
机构：
[1] Seoul National University Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Cancer Research Institute
[3] Seoul Municipal Boramae Hospital,Department of Internal Medicine
[4] Seoul National University College of Medicine,Department of Pathology
[5] Graduate School of Convergence Science and Technology,Department of Molecular Medicine & Biopharmaceutical Sciences
[6] Seoul National University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Colorectal cancer; Oxaliplatin; S-1; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1323 / 1331
页数：8
相关论文
共 50 条
  • [31] Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer
    Park, Sook Ryun
    Hong, Yong Sang
    Lim, Hyeong-Seok
    Seong, Moon-Woo
    Kong, Sun-Young
    Kim, Sun Young
    Park, Young-Iee
    Jung, Kyung Hae
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (05) : 953 - 964
  • [32] Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer
    Li, Jin
    Yin, Jiliang
    Zhu, Xiaodong
    Liu, Yanfei
    Cao, Junning
    Lu, Fangfang
    Zuo, Yunxia
    ANTI-CANCER DRUGS, 2008, 19 (07) : 745 - 748
  • [33] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
  • [34] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Hyeong Su Kim
    Ho Young Kim
    Dae Young Zang
    Ho Suk Oh
    Jang Yong Jeon
    Ji Woong Cho
    Choong Kee Park
    Jong Hyeok Kim
    Min-Jeong Kim
    Hong Il Ha
    Jung Han Kim
    Boram Han
    Hunho Song
    Jung Hye Kwon
    Dae Ro Choi
    Joo Young Jung
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
  • [35] Phase II multi center study of combination therapy with irinotecan and S-1 for metastatic colorectal cancer
    Komatsu, Y.
    Yuki, S.
    Kato, K.
    Kato, S.
    Nakamura, M.
    Tateyarna, M.
    Kudo, M.
    Akita, H.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 199 - 199
  • [36] Phase I/II study of sequential combination with irinotecan and S-1 in patients with metastatic colorectal cancer
    Yoshioka, T.
    Kato, S.
    Gamoh, M.
    Suzuki, T.
    Shibata, H.
    Shimodaira, H.
    Otsuka, K.
    Kakudo, Y.
    Takahashi, S.
    Ishioka, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] RANDOMIZED PHASE II STUDY OF OXALIPLATIN AND S-1 (OS) VERSUS OXALIPLATIN AND CAPECITABINE (XELOX) IN PATIENTS WITH METASTATIC OR RECURRENT COLORECTAL CANCER
    Zang, D. Y.
    Chung, I. J.
    Oh, H.
    Park, K. U.
    Lee, K. H.
    Han, B.
    Choi, D. R.
    Kim, H. S.
    Kim, J. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 193 - 193
  • [38] A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer
    Kim, Jung Han
    Zang, Dae Young
    Chung, Ik-Joo
    Cho, Sang-Hee
    Park, Keon Uk
    Oh, Ho-Suck
    Lee, Kyung Hee
    Lee, Bong Hwa
    Kim, Min-Jeong
    Park, Choong Kee
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Song, Hun Ho
    Jung, Joo Young
    JOURNAL OF CANCER, 2015, 6 (10): : 1041 - 1048
  • [39] Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety
    Hiroaki Tanioka
    Michitaka Honda
    Chihiro Tanaka
    Yoshitaka Morita
    Keiichiro Ishibashi
    Takeshi Kato
    Chu Matsuda
    Masato Kataoka
    Hironaga Satake
    Yoshinori Munemoto
    Kenji Kobayashi
    Masazumi Takahashi
    Ken Nakata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    International Journal of Clinical Oncology, 2019, 24 : 836 - 841
  • [40] Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety
    Tanioka, Hiroaki
    Honda, Michitaka
    Tanaka, Chihiro
    Morita, Yoshitaka
    Ishibashi, Keiichiro
    Kato, Takeshi
    Matsuda, Chu
    Kataoka, Masato
    Satake, Hironaga
    Munemoto, Yoshinori
    Kobayashi, Kenji
    Takahashi, Masazumi
    Nakata, Ken
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (07) : 836 - 841
12345